Видео ютуба по тегу Zaynich

US FDA Committed To A Timeline For Fast Track Approval For Zaynich: Dr. Habil F Khorakiwala
US FDA Committed To A Timeline For Fast Track Approval For Zaynich: Dr. Habil F Khorakiwala
Wockhardt's Breakthrough Antibiotics | Dr Habil Khorakiwala On Zaynich, USFDA, EMA & Growth Plans
Wockhardt's Breakthrough Antibiotics | Dr Habil Khorakiwala On Zaynich, USFDA, EMA & Growth Plans
Habil Khorakiwala On The Zaynich Drug, PLI Schemes, And Challenges In The Pharma Space
Habil Khorakiwala On The Zaynich Drug, PLI Schemes, And Challenges In The Pharma Space
Ожидается, что европейские власти одобрят заявку Зайнича к июлю-августу: об этом заявил председат...
Ожидается, что европейские власти одобрят заявку Зайнича к июлю-августу: об этом заявил председат...
'Global Leadership In Next Decade': Wockhardt Founder On New Zaynich Drug Set for US Market Launch
'Global Leadership In Next Decade': Wockhardt Founder On New Zaynich Drug Set for US Market Launch
USFDA Accepts Wockhardt's Zaynich Application; Growth & R&D Investment Plans? Dr Habil Khorakiwala
USFDA Accepts Wockhardt's Zaynich Application; Growth & R&D Investment Plans? Dr Habil Khorakiwala
Wockhardt Soars 20% After US FDA Accepts NDA For Antibiotic Zaynich; First Time For An Indian Co!
Wockhardt Soars 20% After US FDA Accepts NDA For Antibiotic Zaynich; First Time For An Indian Co!
Wockhardt’s Zaynich Gets Priority FDA Review | India’s First Novel Antibiotic Breakthrough
Wockhardt’s Zaynich Gets Priority FDA Review | India’s First Novel Antibiotic Breakthrough
New novel global antibiotic
New novel global antibiotic "Zaynich" from Wockhardt R&D Lab. Reset Health. Reset Life.
Wockhardt Surges After EMA Grants Accelerated Assessment To Antibiotic Zaynich | CNBC TV18
Wockhardt Surges After EMA Grants Accelerated Assessment To Antibiotic Zaynich | CNBC TV18
Big Boost for Wockhardt: What FDA Nod for Zaynich Means | Group CEO Habil Khorakiwala Exclusive
Big Boost for Wockhardt: What FDA Nod for Zaynich Means | Group CEO Habil Khorakiwala Exclusive
From India to the World: How Zaynich Could Unlock Wockhardt’s Billion-Dollar Global Opportunity
From India to the World: How Zaynich Could Unlock Wockhardt’s Billion-Dollar Global Opportunity
Looking To File Zaynich With The US Regulator In The Next Few Weeks: Wockhardt Group | CNBC TV18
Looking To File Zaynich With The US Regulator In The Next Few Weeks: Wockhardt Group | CNBC TV18
Zaynich To Treat Infections Caused By Various Pathogens: Wockhardt Founder & Chairman Gives Insights
Zaynich To Treat Infections Caused By Various Pathogens: Wockhardt Founder & Chairman Gives Insights
US Tariffs Won’t Derail Plans For Antibiotic Zaynich: Dr Habil F Khorakiwala
US Tariffs Won’t Derail Plans For Antibiotic Zaynich: Dr Habil F Khorakiwala
Wockhardt Prepares USFDA Submission for Zaynich; 2026 Market Entry In Sight | Business News | ET Now
Wockhardt Prepares USFDA Submission for Zaynich; 2026 Market Entry In Sight | Business News | ET Now
Wockhardt में तूफानी तेजी, USFDA ने ZAYNICH को दी मंजूरी!
Wockhardt में तूफानी तेजी, USFDA ने ZAYNICH को दी मंजूरी!
Market Potential For Zaynich Is More Than $1.5 Bn: Habil F Khorakiwala | CNBC TV18
Market Potential For Zaynich Is More Than $1.5 Bn: Habil F Khorakiwala | CNBC TV18